MARKET IS OPEN
Loading latest tickers...
Market Indices
S&P 500
$7,801.77
-0.22%
NASDAQ 100
$31,160.08
-0.21%
DOW JONES
$51,180.00
-0.66%
NASDAQ Composite
$27,538.69
-0.22%
RUSSELL 2000
$2,777.00
-1.29%
CBOE VIX
$15.08
+0.47%
Sector Heatmap
Technology-0.30%
Financials-0.48%
Healthcare+1.03%
Consumer Cycl-0.32%
Consumer Staples-0.12%
Energy-0.58%
Industrials-2.18%
Materials-1.51%
Real Estate-1.29%
Utilities-0.02%
Comm Services-0.35%
QNCX — Quince Therapeutics, Inc. Common Stock
NasdaqQuince Therapeutics, Inc. Common Stock
$26.72
-0.09(-0.34%)
- O
- 26.74
- H
- 27.95
- L
- 26.72
- V
- 12.58K
⏱️ End-of-day dataAs of Oct 7, 2026
Chart
About QNCX
Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
SectorNot available
IPO DateMay 9, 2019
Employees38
Stock ExchangeNasdaq
Ticker SymbolQNCX
Websitehttps://www.quincetx.com
Key Financial Statistics
| Market Cap | $29.70M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $0.79 - $45.50 |
| 52-Week Avg Volume | 2.84M |
| VWAP | $27.18 |
| Transactions | 746 |
| Total Recorded Bars | 1,863 days |